Someone Will Buy Your Life Insurance Policy for More Than the Insurer Offers
A life settlement lets a policyholder sell their policy for more than the insurer would pay to cancel it. The market exists because the insurer surrender value is deliberately low, and it raises questions worth being honest about.
Why the Market Exists
A permanent life insurance policy accumulates value. If the holder no longer wants it, the insurer will pay a surrender value to cancel it. That amount is typically well below what the policy is actually worth to someone willing to keep paying premiums.
That gap is the entire opportunity. An investor can offer the policyholder more than the surrender value, take over the premium payments, and collect the death benefit when the insured dies.
The Arithmetic
The value to a buyer depends on three things: the death benefit, the premiums that must be paid until then, and how long that is expected to be.
| Factor | Effect on value to buyer |
|---|---|
| Larger death benefit | Higher value |
| Shorter life expectancy | Fewer premiums, sooner payout |
| Higher premiums | Lower value |
| Longer life expectancy | More premiums, later payout |
The uncomfortable feature is unavoidable: the investor return improves if the insured dies sooner. That is inherent to the structure rather than a flaw in it, and it should be stated plainly rather than obscured.
The buyer is not betting that someone dies. They are estimating a life expectancy and pricing accordingly. The return is nonetheless better if the estimate proves too long.
Who Sells and Why
The legitimate uses are real. An older policyholder whose children are financially independent may no longer need coverage bought decades ago. Someone facing medical costs may need the capital now. A business may hold a policy on a former executive it no longer employs.
In each case the alternatives are worse. Surrendering to the insurer produces less. Letting the policy lapse produces nothing at all, and lapse is common, which means substantial value is regularly abandoned.
Why Investors Buy
The appeal is the same as with catastrophe bonds: returns uncorrelated with financial markets. Mortality does not depend on interest rates or equity prices.
The risk is specific and asymmetric. If the insured lives longer than projected, the investor pays premiums for additional years and receives the benefit later, which reduces the return substantially. This is longevity risk, and it has caused real losses when life expectancy estimates proved systematically optimistic.
Medical advances make this worse rather than better. A treatment that extends life expectancy for a condition is unambiguously good and damages the returns of anyone who priced policies assuming the old prognosis.
The Regulatory Concerns
The market has attracted regulation for reasons that are easy to understand.
Insurable interest rules exist to prevent people from taking out policies on strangers, and arrangements designed to manufacture policies purely for resale, sometimes called stranger originated life insurance, undermine that principle and have been prohibited in many places.
Disclosure is the second concern. Policyholders selling need to understand what they are giving up, including the tax treatment, the effect on any beneficiaries, and whether alternatives exist. There is a real asymmetry between an individual selling one policy and a firm that buys them routinely.
Privacy is a third. The buyer needs to track the insured status over time, which means ongoing contact about a person health for the benefit of a stranger who profits from their death.
How to Think About It
The market provides genuine value by creating a price for something insurers deliberately underpay for. It also involves an investor whose interests run directly opposite to the wellbeing of a specific identifiable person, which is unusual even in finance.
Both statements are true simultaneously, and any account of this market that presents only one of them is incomplete.
The Bottom Line
Life settlements exist because insurers pay far less to cancel a policy than the policy is worth to someone willing to keep it alive. Sellers get more than surrender value, buyers get returns unrelated to markets, and the return improves the sooner the insured dies. The economics are sound and the structure deserves the scrutiny it receives.